<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1996-10-01" id="root" itemid="87345" xml:lang="en">
<title>USA: Ibah Inc to acquire clinical trial group.</title>
<headline>Ibah Inc to acquire clinical trial group.</headline>
<dateline>BLUE BELL, Pa. 1996-10-01</dateline>
<text>
<p>IBAH Inc said Tuesday it has signed a definitive agreement to acquire Hardardt Group for stock and cash.</p>
<p>Under the deal, IBAH will convert all of the Hardardt Group's stock into about 2.7 million shares of IBAH common stock and $14 million in cash.</p>
<p>Judy Hardardt, the founder and president of Hardardt Group, would become a member of IBAH's board of directors, Ibah said.</p>
<p>The deal was expected to close on October 1.  </p>
<p>Hardardt Group, which is based in Parsippany, N.J., is a research organization specializing in management of clinical trials of drug development.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<dc element="dc.date.created" value="1996-10-01" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1996-10-01" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="BLUE BELL, Pa." />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>